ABIM Med Oncology Practice Questions - ABIM Medical Oncology Subspecialty Certification Exam

Access More Questions

A 58-year-old woman with HR+/HER2-low (IHC 1+) metastatic breast cancer has progressed after two prior lines of chemotherapy in the metastatic setting. Which therapy demonstrated OS benefit in DESTINY-Breast04?

Sacituzumab govitecan Trastuzumab deruxtecan (T-DXd) Eribulin Capecitabine

Correct Answer:

Trastuzumab deruxtecan (T-DXd)

Access more questions from this quiz

Continue to ABIM Med Oncology Practice Questions - ABIM Medical Oncology Subspecialty Certification Exam for more practice questions and the full quiz experience.

Access More Questions